We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+15.83%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$7.92B
AUM Growth
+$2.08B
(+36%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
16.61%
Top 10 Holdings %
Top 10 Hldgs %
41.43%
Holding
197
New
67
Increased
35
Reduced
38
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$372M |
| 2 |
Dollar General
DG
|
+$308M |
| 3 |
HCA Healthcare
HCA
|
+$305M |
| 4 |
Charter Communications
CHTR
|
+$180M |
| 5 |
CF Industries
CF
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$210M |
| 2 |
LyondellBasell Industries
LYB
|
+$202M |
| 3 |
Boeing
BA
|
+$181M |
| 4 |
FedEx
FDX
|
+$151M |
| 5 |
American International
AIG
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.51% |
| 2 | Healthcare | 20.57% |
| 3 | Energy | 18.19% |
| 4 | Industrials | 10.52% |
| 5 | Materials | 5.15% |
Similar funds
CIP
IMRF
SF
CMTU
PGFC
SI
EGM
PA
PointState Capital's Q4 2013 Portfolio in Review
As of Q4 2013, PointState Capital held 197 positions worth $7.92B, up 36% from $5.84B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
PointState Capital deployed $1.31B of net new capital in Q4 2013, opening 67 new positions and adding to 35 existing holdings. Its largest new stake was Teva Pharmaceuticals: 9,445,400 shares worth $379M.
By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $210M trimmed.
- PointState Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 9,445,400 shares worth $379M.
- PointState Capital added most to Dollar General in Q4 2013, an estimated $308M increase.
- PointState Capital's biggest Q4 2013 reduction was Allergan Inc, cutting an estimated $210M.
- PointState Capital fully exited LyondellBasell Industries in Q4 2013, selling an estimated $202M.
- PointState Capital's ten largest holdings make up 41% of its $7.92B portfolio in Q4 2013.
- PointState Capital opened 67 new positions and closed 55 in Q4 2013.
- PointState Capital's portfolio value rose 36% quarter-over-quarter to $7.92B.
Based on PointState Capital's 13F filing for Q4 2013, filed 14 Feb 2014.